Clinical Trial: A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)

U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06893081) titled 'A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)' on March 18.

Brief Summary: The goal of this study is to learn what happens to MK-8527 in a healthy person's body over time when MK-8527 is given alone and with the medication CBZ.

Study Start Date: April 21

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: MK-8527

Oral Tablet

DRUG: CBZ

Oral Extended-release Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Published by HT Digital Content Services with permission from Health Daily Digest....